HOME >> MEDICINE >> NEWS
Worsening anemia signals poorer outcomes in men treated for advanced prostate cancer

PORTLAND, Ore. -- Researchers from the Oregon Health & Science University Cancer Institute and Southwest Oncology Group have identified a new method of determining how men with advanced prostate cancer will respond to treatment. They found that worsening anemia during the first three months of hormonal therapy for prostate cancer that has spread predicts shorter survival and earlier relapse.

"These results suggest that by monitoring anemia during the first three months of treatment, we can provide men with a better idea of how well they will fare," said principal investigator Tomasz Beer, M.D., director of the prostate cancer research program in the OHSU Cancer Institute. Beer will present results of this study at the 101st Annual Meeting of the American Urological Association in Atlanta on Tues., May 23.

Researchers also found that race alone was not a strong predictor of survival or disease progression. However, they found that men with the same hemoglobin levels before treatment experienced significantly different overall and progression-free survival depending on whether they were black or white. Hemoglobin levels in the blood are measured to monitor anemia. Lower levels of hemoglobin are considered anemic.

"Outcomes for prostate cancer have always been worse for black men than their white counterparts and the reasons behind this have not been fully understood," Beer said. "Differences in anemia could help us understand why blacks do worse and maybe make it possible to do something about it."

Overall, researchers found that anemic blacks fare worse than anemic whites and that blacks with high baseline hemoglobin fare better than whites with similar hemoglobin levels.

"Our study was not designed to answer questions about this complex and novel finding, but we are examining a number of hypotheses," Beer said.

Anemia is common among newly diagnosed prostate cancer patients with metastatic disease
'"/>

Contact: Rachel MacKnight
macknigh@ohsu.edu
503-494-8231
Oregon Health & Science University
23-May-2006


Page: 1 2 3

Related medicine news :

1. Researchers urge caution in using ESAs for cancer-related anemia
2. Mortality rate increases for kidney recipients with anemia
3. Exercise helps breast cancer patients avoid anemia
4. How bad is malaria anemia? It may depend on your genes
5. Immune culprit in malaria-associated anemia
6. New drug poised to radically change the treatment of severe anemias
7. Hepatitis C drug proves cost-effective in helping patients with treatment-induced anemia
8. Oral liquid hydroxyurea promising for long-term use in babies with sickle cell anemia
9. Study examines effectiveness of anti-anemia drug in treatment of cancer patients
10. Study says normal but out-of-control enzyme may be culprit that signals some cells to become cancer
11. Targeted cancer drugs may work by disrupting balance of cellular signals

Post Your Comments:
(Date:5/27/2015)... (PRWEB) May 27, 2015 Holly CaSaroll, founder ... on preventing burns, aging and cancer. The skin is the ... daily. Every year more than 3.5 million cases of skin ... percent are caused by the sun's ultraviolet rays (UVR). ... themselves. , 1. Avoid the sun between the ...
(Date:5/27/2015)... May 27, 2015 CRN International, the ... as its new Chief Financial Officer. , Prinner most ... prior to that held financial/operational executive positions at telecom ... Corp., Conversent Communications, Utilicom, and SNET. His accounting ... , At CRN, Prinner will be able to tap ...
(Date:5/27/2015)... Antonio, TX (PRWEB) May 27, 2015 ... “Pass The Torch” Addiction Treatment Scholarship Award. From June ... awarded $10,000 to 50 drug and alcohol addiction treatment ... afford treatment. Scholarships were drawn at random at addiction ... Director for Sky Toxicology, Matt Green said, “Sky Toxicology ...
(Date:5/27/2015)... NC (PRWEB) May 27, 2015 Danish ... “front line” biomarkers that have the potential to help ... here to read the full story that has ... Aalborg University in Aalborg, Denmark say new biomarkers found ... the outlook for patients with malignant mesothelioma . ...
(Date:5/27/2015)... (PRWEB) May 27, 2015 With the ... Studios, editors can quickly and easily add filmic color grades ... CUBE LUT files. , FCPX LUT Cross Processed Plugin can ... to contemporary looks and everything in between. , FCPX LUT ... be used in many different softwares. With the FCPX LUT ...
Breaking Medicine News(10 mins):Health News:In Recognition of National Melanoma Awareness Month, Beauty Guru Details Skin Tips to Prevent Cancer and Premature Aging 2Health News:CRN International Names New Chief Financial Officer 2Health News:Sky Toxicology Reaches Their $500,000 Goal in Drug and Alcohol Addiction Treatment Patient Scholarship Awards 2Health News:Sky Toxicology Reaches Their $500,000 Goal in Drug and Alcohol Addiction Treatment Patient Scholarship Awards 3Health News:New Report Highlights Current and Emerging Biomarkers for Mesothelioma, According to Surviving Mesothelioma 2Health News:Developers at Pixel Film Studios Release FCPX LUT Cross Processed Plugin for Final Cut Pro X 2
(Date:5/27/2015)... Biosensors International Group, Ltd. ("Biosensors " or ... a developer, manufacturer and marketer of innovative medical devices, ... ("Q4 FY15") and fiscal full year ended 31 March ... , Q4 FY15: , Total revenue ... of Fiscal Year 2014 ("Q4 FY14") due to licensing ...
(Date:5/27/2015)... 27, 2015  PDL BioPharma, Inc. (PDL) (NASDAQ: ... , the company,s president and chief executive officer, will ... week in New York City.  The presentation, which will ... at 11:30 a.m. EDT. To access the ... to the Company,s website at http://www.pdl.com and ...
(Date:5/27/2015)... International, Inc. (NASDAQ: BDSI ) announced that Dr. Mark ... present at two important upcoming healthcare conferences: ... Time Grand Hyatt, New York City , ... Growth Stock Conference Tuesday, June 9 2:50 PM Central Time (3:50 ... , Dr. Sirgo will be discussing progress with ...
Breaking Medicine Technology:Biosensors Reports Financial Results for Fiscal Year 2015 2Biosensors Reports Financial Results for Fiscal Year 2015 3Biosensors Reports Financial Results for Fiscal Year 2015 4Biosensors Reports Financial Results for Fiscal Year 2015 5Biosensors Reports Financial Results for Fiscal Year 2015 6Biosensors Reports Financial Results for Fiscal Year 2015 7PDL BioPharma to Present at Jefferies 2015 Global Healthcare Conference 2BioDelivery Sciences to Present at the Jefferies 2015 Healthcare Conference and the William Blair Growth Stock Conference 2BioDelivery Sciences to Present at the Jefferies 2015 Healthcare Conference and the William Blair Growth Stock Conference 3
Cached News: